📰 GPCR Weekly News, July 22 to 28, 2024
In the fast-paced world of pharmaceuticals and drug discovery, it is crucial for professionals to stay informed about the latest advancements and breakthroughs. We have 18 GPCR papers, four industry news articles, and two job ads.
This week's highlight includes congrats to:
Clementine E Philibert and Mikel Garcia-Marcos for their work on Smooth operator(s): dialing up and down neurotransmitter responses by G-protein regulators
András D Tóth, Gábor Turu, and László Hunyady for their research on Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors
Antonios Drakopoulos, Peter Gmeiner, Davide Calebiro, Michael Decker, et al. for their study on Design, Synthesis, and Characterization of New δ Opioid Receptor-Selective Fluorescent Probes and Applications in Single-Molecule Microscopy of Wild-Type Receptors
Early-Bird Registration Now Open for Premium Members!
We’re thrilled to announce our upcoming courses with Dr. Terry Kenakin! Get your premium membership and enjoy a 25% exclusive discount (1 month FREE trial!). Don’t miss out—secure your spot today!
Courses Schedule and Benefits
Every Thursday at 10 am EST
Online Lectures
1:1 meeting with Dr. Terry Kenakin
Reading Materials
Access to the private group
Certificate
Explore:
Key metrics for assessing ligand pharmacology (affinity, efficacy, co-operativity)
Mechanisms of action for new GPCR ligands
Essentials for effective GPCR discovery
Discover:
Advanced cellular assays for GPCR ligand behavior
Real-time kinetics for predicting activity
Unique drug profiles from new ligands and GPCR behaviors
Join us in vibrant Mexico City from October 23-25, 2024, for the 11th Adhesion GPCR Workshop! Connect with fellow scientists and dive into the latest in adhesion GPCR biology.
Logo Contest: Submit your design by August 15, 2024, to have your artwork featured at the event.
Sponsorship Opportunities: Boost your brand’s visibility at this scientific event. Contact us at Hello@DrGPCR.com to learn more.
We look forward to your participation!
Let’s dive into the Classified GPCR News from July 22 to 28, 2024
Activating an invertebrate bistable opsin with the all-trans 6.11 retinal analog
Ligand bias at the muscarinic acetylcholine receptor family: opportunities and challenges
Modulating Vertebrate Physiology by Genomic Fine-Tuning of GPCR Functions
Smooth operator(s): dialing up and down neurotransmitter responses by G-protein regulators
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors
Activation of a GPCR, ORL1 receptor: A novel therapy to prevent heart failure progression
Comments